Skip to main content
Sugentech, Inc. logo

Sugentech, Inc. — Investor Relations & Filings

Ticker · 253840 ISIN · KR7253840003 KO Manufacturing
Open in API
Filings indexed 297 across all filing types
Latest filing 2019-12-13 Regulatory Filings
Country KR South Korea
Listing KO 253840

About Sugentech, Inc.

https://www.sugentech.com/en/

Sugentech, Inc. is an in-vitro diagnostics (IVD) company that develops and commercializes diagnostic solutions by integrating biotechnology, nanotechnology, and information technology. The company's product portfolio serves diverse healthcare settings, from large hospitals and laboratories to smaller clinics and home users. Key offerings include automated multi-immunoblot systems, point-of-care testing (POCT) platforms, and self-diagnostic kits for personal use, such as ovulation and pregnancy tests. Sugentech leverages proprietary technologies in developing high-level antibodies and advanced nanoparticles to create highly sensitive and precise immunochemical assays, underpinning its digital healthcare diagnostic platform for personalized medicine.

Recent filings

Filing Released Lang Actions
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory notice regarding the suspension of share registration (closing of the shareholder register) for the purpose of determining shareholders eligible to attend the 9th Annual General Meeting. It does not contain the full report or proxy materials, but rather serves as a formal regulatory announcement of a corporate action. Since it does not fit into specific categories like dividend announcements or share buybacks, it falls under the general regulatory filing category.
2019-12-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share ownership and transaction history (specifically a '장내매수' or open-market purchase) of a company executive (Park, Jongyoon) at Sugentech. This type of filing is a standard disclosure for insider trading or changes in executive shareholdings, which corresponds to the 'Director's Dealing' category.
2019-12-12 Korean
기타경영사항(특허권취득)(자율공시)(막 기반 다중튜브를 포함하는 생체 물질 분석 장치)
Regulatory Filings Classification · 95% confidence The document is a regulatory disclosure from Sugentech regarding the acquisition of a patent ('기타 경영사항(특허권 취득)'). It details the patent name, content, and utilization plan. Since it is a specific corporate announcement regarding a business development (patent acquisition) that does not fit into financial reporting, M&A, or governance categories, it falls under the general regulatory filing category.
2019-11-19 Korean
분기보고서 (2019.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Sugentech' (주식회사 수젠텍) covering the period from January 1, 2019, to September 30, 2019. It contains detailed financial information, business descriptions, capital changes, and management discussions, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2019
2019-11-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities. It details the shareholding changes of a specific individual (Sohn Mijin, CEO of Sugentech) due to market transactions. This type of filing is categorized as a Director's Dealing (DIRS) report, as it tracks insider share transactions.
2019-10-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a standard regulatory disclosure for insider trading or changes in share ownership by company directors/executives. In the provided classification schema, 'Director's Dealing' (DIRS) is the correct category for reports detailing personal share transactions by company directors and executives.
2019-10-30 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.